{
Novartis

People

}
001122334455554433221100
001122334455554433221100

Swiss companies commit to science based targets for CO2 reduction

A total of 224 Swiss companies have committed to CO2 reduction targets aligned with the Paris Climate Agreement by joining the Science Based Targets initiative (SBTi). This includes major corporations like ABB, Givaudan, and Nestlé, with over 80 new members since the start of the year. Only three companies have withdrawn from the initiative.
SWI swissinfo.ch
Novartis AG Nestlé S.A. Givaudan SA Holcim AG ABB Ltd CHE Nestlé Holcim Givaudan Novartis ABB Show more
Regulatory & Legal, News Article
11:11 16.11.2024

Swiss stock market shows minimal movement amid mixed corporate earnings and monetary policy concerns

The Swiss stock market showed minimal movement, with the SMI down 0.07% to 8215.17 points and the SPI down 0.04% to 8908.21 points. Credit Suisse saw a surprising profit but fell 2.25%, while UBS and Julius Bär also declined. Defensive stocks like Nestlé and Roche had mixed results, and Logitech surged 7.83% in the broader market.
TicinoNews
Richemont DNS Inc. Julius Bär Stiftung Novartis AG Logitech SA Clariant AG Hoffmann-La Roche AG Swatch AG Credit Suisse Anlagestiftung Swiss Life AG Swiss Re AG Zurich Insurance Group AG ABB Ltd UBS AG LafargeHolcim Ltd. Nestlé S.A. BOBST MEX SA Basel Cantonal Bank Adecco Group AG CHE Swiss Re Novartis Roche Nestlé Bobst Zurich Logitech Julius Bär ABB LafargeHolcim Swatch Credit Suisse UBS Richemont Basel Cantonal Bank Adecco Swiss Life Clariant Show more
TradFi, Market Report
18:41 09.11.2024

Swiss stock exchange declines as banking stocks face renewed pressure

The Swiss stock exchange turned negative, with the SMI down 0.30% to 8060.69 points and the SPI losing 0.37% to 8704.05 points amid low trading volumes. Banking stocks faced pressure, particularly UBS (-1.86%) and Credit Suisse (-1.52%), due to uncertainties around Brexit and low interest rates. Defensive stocks like Novartis (+0.44%) showed resilience, while Sulzer surged 10.59% following its acquisition of Geka.
TicinoNews
United States Dollar Richemont DNS Inc. Julius Bär Stiftung Novartis AG gategroup GmbH Hoffmann-La Roche AG Swatch AG EFG International AG Credit Suisse Anlagestiftung Swiss Life AG GEKA GmbH Swiss Re AG Zurich Insurance Group AG SGS SA ABB Ltd Sulzer Ltd UBS AG Geberit AG LafargeHolcim Ltd. Nestlé S.A. Adecco Group AG BSI Group AG CHE Tidjane Thiam Novartis Show more
TradFi, Market Report
17:06 09.11.2024

Swiss stock exchange rallies as oil prices rise and key stocks gain

The Swiss stock exchange started the week positively, with the SMI Guiding Values Index rising 1.51% to 7982.44 points, while the SPI gained 1.50% to 8311.73 points. The market's optimism is fueled by increasing oil prices, benefiting companies like Transocean and cyclical stocks such as ABB and Adecco. Notable gains were also seen in banking and insurance sectors, with UBS and Swiss Re performing well, while EFG International faced a decline after announcing its acquisition of BSI.
TicinoNews
United States Dollar Julius Bär Stiftung Adecco Group AG Hoffmann-La Roche AG Nestlé S.A. LafargeHolcim Ltd. ABB Ltd Swiss Re AG Transocean Ltd. Novartis AG UBS AG Zurich Insurance Group AG EFG International AG Credit Suisse Anlagestiftung FRA CHE EFG International Novartis Adecco Transocean Nestlé ABB Julius Bär Swiss Re Roche Zurich UBS LafargeHolcim Credit Suisse Show more
TradFi, Market Report
20:10 08.11.2024

global lasik eye surgery market trends and growth forecast to 2033

The global LASIK eye surgery market is projected to grow significantly, with North America expected to dominate due to advanced healthcare facilities and rising eye disorder incidences. The wavefront-optimized segment is anticipated to hold the largest market share, driven by improvements in visual acuity and the increasing demand for less invasive procedures. Asia-Pacific is set to experience the fastest growth, fueled by a large patient base, rapid medical technology advancements, and government initiatives to enhance healthcare awareness.
Spherical Insights
Johnson and Johnson Private sector Abbott-Action Inc. Alcon Inc. Bausch+Lomb Incorporated NIDEK CO., LTD FRA CHN ESP BRA KOR IND ZAF ITA ARG CAN USA RUS JPN MEX GBR DEU ARE AUS Carl Zeiss Carl ZEISS AG Novartis Johnson Johnson Show more
Healthcare, Market Report
23:16 06.11.2024

key corporate earnings and investor events shaping the stock market this week

This week marks a significant period in the third quarter reporting season, starting with Rieter's investor day on Monday. Key healthcare companies, including Novartis and Idorsia, will report on Tuesday, alongside Straumann and Clariant, while UBS and Sunrise are set to present their results on Wednesday. The week continues with Geberit and Swisscom on Thursday, as various companies navigate challenges and opportunities in their respective sectors.
Finanz und Wirtschaft
Euro United States Dollar Novartis AG UBS AG Swisscom AG CHE DEU Novartis Ubs Idorsia Straumann Rieter Show more
TradFi, Market Report
05:00 28.10.2024

diabetic retinopathy market poised for significant growth driven by rising diabetes cases

The global diabetic retinopathy devices market, valued at USD 12.47 billion in 2022, is projected to grow at a robust CAGR of around 30% through 2030, driven by rising diabetes cases and an aging population. Non-proliferative diabetic retinopathy is expected to dominate, while North America will lead regionally, with significant contributions from the APAC region due to its large diabetic population. Key players include F. Hoffmann-La Roche, Novartis, and Regeneron, focusing on innovative treatments and technologies.
Market Research Reporting & Analysis Agency in India
Indian Rupee Pakistani Rupee Chinese Yuan United States Dollar Regeneron Pharmaceuticals, Inc. Sanofi Coherus BioSciences, Inc. Novartis AG Bayer AG Kodiak Sciences Inc. HANLIM PHARM.CO.LTD Intas Pharmaceuticals Ltd. SUN Pharmaceutical Industries Ltd. F. Hoffmann-La Roche Ltd. PAK CHN IND Bayer Regeneron Pharmaceuticals Sun Yat-Sen Novartis F. Hoffmann-La Roche Show more
Healthcare, Market Report
14:04 26.10.2024

large drug stocks poised to exceed q3 earnings expectations

The drug and biotech sector is experiencing a strong earnings season, highlighted by Johnson & Johnson's recent performance, which exceeded estimates and led to an upward revision of revenue expectations. Five large drug companies—Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals, and Biogen—are anticipated to outperform in their upcoming quarterly results, with Novo Nordisk showing a positive Earnings ESP of +1.02% and a Zacks Rank #3. Overall, the Medical sector is projected to see a 6.4% rise in fourth-quarter earnings and an 8.5% increase in revenues.
@YahooFinance
Novartis AG Novo Nordisk A/S Biogen Inc. Pfizer Inc. Regeneron Pharmaceuticals, Inc. DNK Regeneron Pharmaceuticals Novo Nordisk Biogen Novartis Pfizer Show more
Finance & Economy, Market Report
14:31 22.10.2024

Sanofi invests 300 million euros in joint venture for radiopharmaceuticals

Sanofi is investing 300 million euros for a 16% stake in a new joint venture with Orano Med to develop radiopharmaceuticals targeting rare cancers, particularly using the radioisotope lead-212. This partnership aims to leverage expertise in biopharma and nuclear technology to advance cancer treatment. The joint venture is valued at 1.9 billion euros, following Sanofi's recent licensing of an experimental drug for neuroendocrine tumors.
BioPharma Dive
Euro Eli Lilly and Company Orano Group Bristol-Myers Squibb Company Novartis AG AstraZeneca PLC Bayer AG Sanofi FRA USA Paul Hudson Bayer AstraZeneca Eli Lilly Novartis Show more
Healthcare, Press Release
13:20 17.10.2024

global pharmaceutical and healthcare market projected to reach 1924 billion by 2032

Rising healthcare costs are straining patients, payers, and providers, limiting access to care and pressuring the pharmaceutical industry to maintain lower prices. The global pharmaceuticals and healthcare market is projected to grow from $1,245.88 billion in 2021 to $1,924.24 billion by 2032, driven by technological advances and demographic changes. However, regulatory barriers and increasing costs pose significant challenges to market growth.
businessresearchinsights.com
United States Dollar Hoffmann-La Roche AG Johnson & Johnson Novartis AG Merck & Co., Inc. AbbVie Inc. CAN FRA GBR USA ISR JPN DNK DEU Merck & Co Roche Johnson & Johnson AbbVie Novartis Show more
Healthcare, Market Report
09:00 07.10.2024
Trending
Subcategory
Corporate News Industry Trends Startups & Entrepreneurship Retail and Consumer Goods Supply Chain Management Global Trade Developments Government Economic Policies Stock Market Updates Industry Mergers & Acquisitions Fintech Startups CEO Changes Energy Sector Developments Workplace Trends Emerging Startups Funding Rounds & Investments AI Applications Private Equity Deals Venture Capital Investments AI Innovations Finance Mergers & Acquisitions
Countries:
USA CHN IND ARE SAU JPN GBR SGP KOR AUS IDN VNM HKG MYS DEU ISR CAN BGD QAT TWN
Companies:
Apple Inc. Google Inc. Tesla, Inc. Amazon.com, Inc. Microsoft Corporation Tesmec S.p.A. Alphabet Inc. OpenAI ERC USD Walmart Inc. SWIGGY LIMITED Mistral 1 TENCENT NVIDIA Corporation Foxconn Technology Co., Ltd. Hollywood Bowl Group PLC NASDAQ Composite Wise plc Mastercard Inc Bose Corporation Concrete Credit Limited
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro Japanese Yen British Pound Sterling United Arab Emirates Dirham Vietnamese Đồng Algerian Dinar South Korean Won New Zealand Dollar Saudi Riyal Thai Baht Australian Dollar Indonesian Rupiah Singapore Dollar Omani Rial Bahraini Dinar Qatari Riyal Egyptian Pound
People:
Donald Trump Elon Musk Asmaa Naga Basma Bushnak Maha Taibah Ursula von der Leyen Hossam Ahmed Tasneem Islam Scott Bessent Imad Boumahdi Joe Biden Sri Mulyani Mark Carney Howard Lutnick Yongqiang He Xi Jinping Aman Gupta Cristina Pitarch Mohamed Alkuwaiti Afeef Zaman

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.